Heart Diseases
1,201
60
93
958
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Published Results
71 trials with published results (6%)
Research Maturity
958 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
32 terminated out of 1201 trials
96.8%
+10.3% vs benchmark
13%
156 trials in Phase 3/4
7%
71 of 958 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 958 completed trials
Clinical Trials (1201)
The PulsePoint Study
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Abbott Structural Heart Device Registry
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Genetic Testing of CYP2C19 in Prognostic Evaluation of Long-Term Major Adverse Cardiac and Vascular Events
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
The Leadless AV Versus DDD Pacing Study
BAG3-DCM Natural History Study
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
Archival of Human Biological Samples in CU-Med Biobank
Monocyte Priming When Consuming a Western Diet
Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology
Lumason® Infusion vs. Bolus Administrations
Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Multivessel TALENT
PKP2-ACM Natural History Study